Novavax, Inc.
NVAX
$8.05
-$0.09-1.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -59.36% | -5.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -59.36% | -5.18% | |||
| Cost of Revenue | -35.70% | -17.31% | |||
| Gross Profit | -157.56% | 142.30% | |||
| SG&A Expenses | -5.13% | 480.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.11% | 18.50% | |||
| Operating Income | -406.54% | -147.91% | |||
| Income Before Tax | -507.52% | -147.51% | |||
| Income Tax Expenses | 73.71% | 161.97% | |||
| Earnings from Continuing Operations | -462.50% | -154.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -462.50% | -154.15% | |||
| EBIT | -406.54% | -147.91% | |||
| EBITDA | -585.28% | -126.74% | |||
| EPS Basic | -458.35% | -153.90% | |||
| Normalized Basic EPS | -1,418.49% | -110.52% | |||
| EPS Diluted | -458.35% | -153.90% | |||
| Normalized Diluted EPS | -1,418.49% | -110.69% | |||
| Average Basic Shares Outstanding | 0.79% | 0.46% | |||
| Average Diluted Shares Outstanding | 0.79% | -1.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||